A total of 61 Equity Offering deals (pending and completed) were announced in the Healthcare of United Kingdom, in the last twelve months resulting in a total deal value of over $2,333.0 million. In the LTM period, September 2021 turned out to be the most prolific in terms of deal size, with a total deal value of $578.7 million, resulting in an average deal value of $192.9 million during that month. On the other hand, the month of May 2022 was the most prolific in terms of deal volume, recording a total of 10 deals, resulting in an average deal value of $19.9 million during that month.
Of the 61 deals, the deal secured between Bill & Melinda Gates Foundation; SOFTBANK CORP. (USA) and Exscientia Plc, was the largest Equity Offering deal in the United Kingdom Healthcare sector, which was valued at $160.0 million and was completed on September 30, 2021. The second-largest deal was between Novo Holdings AS and Oxford BioMedica Plc, while the third-largest deal was between Serum Institute of India Pvt Ltd and Oxford BioMedica Plc. The Novo Holdings AS-Oxford BioMedica Plc deal and the Serum Institute of India Pvt Ltd-Oxford BioMedica Plc deal were valued at $107.3 million and $68.3 million, respectively. The fourth-largest deal was between Sanofi-Gyroscope Therapeutics Holdings Ltd valued at $60.0 million, whereas the deal between Canaccord Genuity Group Inc-Creo Medical Group Plc valued at $43.3 million was the fifth-largest deal.
Cumulatively, the top five deals amounted to $438.8 million and accounted for nearly 18.81% of the total deals (by value) announced during the last twelve months.
United States of America
China
United States of America
Japan
Ireland
United States of America
United Kingdom
Canada
United States of America
United States of America
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward